 Sheera Rosenbaum
Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Melanoma | 11 | 2025 | 757 | 2.060 |
Why?
| | Skin Neoplasms | 9 | 2025 | 852 | 1.040 |
Why?
| | SOXE Transcription Factors | 3 | 2024 | 19 | 1.010 |
Why?
| | Cell Plasticity | 1 | 2025 | 34 | 0.920 |
Why?
| | Chemokine CCL2 | 1 | 2025 | 115 | 0.920 |
Why?
| | Neoplasms | 3 | 2025 | 2644 | 0.770 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2025 | 201 | 0.770 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 445 | 0.740 |
Why?
| | NF-kappa B | 1 | 2025 | 691 | 0.710 |
Why?
| | B7 Antigens | 1 | 2020 | 14 | 0.650 |
Why?
| | Forkhead Transcription Factors | 1 | 2020 | 190 | 0.610 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2021 | 189 | 0.590 |
Why?
| | Cell Line, Tumor | 13 | 2025 | 3399 | 0.570 |
Why?
| | Genes, Essential | 1 | 2017 | 22 | 0.560 |
Why?
| | Proto-Oncogene Proteins B-raf | 6 | 2025 | 226 | 0.550 |
Why?
| | Cell Proliferation | 4 | 2021 | 2473 | 0.490 |
Why?
| | Gene Expression Regulation, Neoplastic | 7 | 2025 | 1396 | 0.450 |
Why?
| | Tumor Microenvironment | 3 | 2025 | 671 | 0.340 |
Why?
| | Mice, Inbred NOD | 2 | 2021 | 601 | 0.310 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 209 | 0.300 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 2 | 2024 | 25 | 0.260 |
Why?
| | COUP Transcription Factor I | 1 | 2025 | 2 | 0.240 |
Why?
| | Epithelial-Mesenchymal Transition | 2 | 2025 | 209 | 0.240 |
Why?
| | Receptor, ErbB-3 | 2 | 2015 | 44 | 0.240 |
Why?
| | Neuregulin-1 | 2 | 2015 | 46 | 0.230 |
Why?
| | Immunotherapy | 2 | 2021 | 640 | 0.220 |
Why?
| | Rhabdomyosarcoma | 1 | 2024 | 72 | 0.210 |
Why?
| | Mice | 5 | 2025 | 17731 | 0.210 |
Why?
| | Animals | 7 | 2025 | 36768 | 0.210 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2024 | 214 | 0.200 |
Why?
| | Neoplasm Metastasis | 1 | 2025 | 654 | 0.190 |
Why?
| | Cell Death | 1 | 2024 | 370 | 0.190 |
Why?
| | Neoplasm Proteins | 1 | 2025 | 432 | 0.190 |
Why?
| | Receptors, Tumor Necrosis Factor, Member 14 | 1 | 2021 | 6 | 0.190 |
Why?
| | Carcinoembryonic Antigen | 1 | 2021 | 39 | 0.190 |
Why?
| | Signal Transduction | 4 | 2025 | 5065 | 0.190 |
Why?
| | Cerebellar Neoplasms | 1 | 2023 | 155 | 0.190 |
Why?
| | Medulloblastoma | 1 | 2023 | 196 | 0.180 |
Why?
| | Mice, Inbred C57BL | 3 | 2021 | 5744 | 0.180 |
Why?
| | Humans | 16 | 2025 | 136783 | 0.180 |
Why?
| | Mice, SCID | 1 | 2021 | 367 | 0.170 |
Why?
| | Cell Adhesion Molecules | 1 | 2021 | 181 | 0.170 |
Why?
| | Chromatin | 1 | 2024 | 518 | 0.170 |
Why?
| | Databases, Genetic | 1 | 2021 | 236 | 0.170 |
Why?
| | Tumor Burden | 1 | 2021 | 309 | 0.170 |
Why?
| | Cell Adhesion Molecule-1 | 1 | 2019 | 1 | 0.160 |
Why?
| | Twist-Related Protein 1 | 1 | 2019 | 9 | 0.160 |
Why?
| | Aminopyridines | 1 | 2019 | 99 | 0.150 |
Why?
| | Melanoma, Experimental | 1 | 2020 | 113 | 0.150 |
Why?
| | Antigens, CD | 1 | 2021 | 522 | 0.150 |
Why?
| | Mutation | 4 | 2025 | 3953 | 0.150 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2024 | 1242 | 0.150 |
Why?
| | Pyrroles | 1 | 2019 | 211 | 0.150 |
Why?
| | GTP Phosphohydrolases | 2 | 2015 | 92 | 0.150 |
Why?
| | Nuclear Proteins | 2 | 2023 | 710 | 0.150 |
Why?
| | Disease Progression | 1 | 2025 | 2750 | 0.140 |
Why?
| | Survival Analysis | 1 | 2020 | 1319 | 0.130 |
Why?
| | Cytokines | 1 | 2024 | 2088 | 0.120 |
Why?
| | Immunologic Factors | 1 | 2017 | 237 | 0.120 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2015 | 56 | 0.120 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2021 | 913 | 0.120 |
Why?
| | Epidermal Growth Factor | 1 | 2015 | 174 | 0.120 |
Why?
| | Running | 1 | 2017 | 230 | 0.120 |
Why?
| | Proteins | 1 | 2019 | 1009 | 0.100 |
Why?
| | B7-H1 Antigen | 1 | 2015 | 217 | 0.100 |
Why?
| | Tumor Suppressor Proteins | 1 | 2015 | 327 | 0.100 |
Why?
| | Receptor, ErbB-2 | 1 | 2015 | 342 | 0.100 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2015 | 429 | 0.100 |
Why?
| | Membrane Proteins | 2 | 2015 | 1162 | 0.100 |
Why?
| | Macrophages | 1 | 2019 | 1541 | 0.090 |
Why?
| | RNA, Messenger | 1 | 2020 | 2831 | 0.090 |
Why?
| | T-Lymphocytes | 1 | 2020 | 1998 | 0.090 |
Why?
| | Cell Movement | 1 | 2015 | 969 | 0.090 |
Why?
| | Neoplasm Invasiveness | 2 | 2025 | 507 | 0.090 |
Why?
| | Fibroblasts | 1 | 2015 | 989 | 0.080 |
Why?
| | Aged, 80 and over | 1 | 2020 | 7569 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2023 | 455 | 0.070 |
Why?
| | Female | 3 | 2025 | 72840 | 0.070 |
Why?
| | Male | 3 | 2021 | 67361 | 0.060 |
Why?
| | PAX3 Transcription Factor | 1 | 2024 | 17 | 0.060 |
Why?
| | Paired Box Transcription Factors | 1 | 2024 | 46 | 0.060 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2024 | 62 | 0.050 |
Why?
| | Tyrosine | 1 | 2023 | 222 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2023 | 171 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2025 | 864 | 0.050 |
Why?
| | Sequence Analysis, DNA | 2 | 2015 | 811 | 0.050 |
Why?
| | Aged | 1 | 2020 | 23729 | 0.040 |
Why?
| | Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 15 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 658 | 0.040 |
Why?
| | Tissue Array Analysis | 1 | 2019 | 57 | 0.040 |
Why?
| | Protein Kinase Inhibitors | 1 | 2025 | 916 | 0.040 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2019 | 71 | 0.040 |
Why?
| | Middle Aged | 1 | 2020 | 33200 | 0.040 |
Why?
| | Adult | 1 | 2020 | 37616 | 0.030 |
Why?
| | Transfection | 1 | 2019 | 945 | 0.030 |
Why?
| | Apoptosis | 2 | 2015 | 2548 | 0.030 |
Why?
| | Cyclin B1 | 1 | 2015 | 6 | 0.030 |
Why?
| | Syk Kinase | 1 | 2015 | 21 | 0.030 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2015 | 75 | 0.030 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2015 | 73 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2015 | 239 | 0.030 |
Why?
| | Exome | 1 | 2015 | 231 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2019 | 1250 | 0.030 |
Why?
| | Immune System | 1 | 2015 | 177 | 0.030 |
Why?
| | RNA Interference | 1 | 2015 | 464 | 0.030 |
Why?
| | Phenotype | 1 | 2022 | 3199 | 0.030 |
Why?
| | Ligands | 1 | 2015 | 664 | 0.030 |
Why?
| | MAP Kinase Signaling System | 1 | 2015 | 321 | 0.030 |
Why?
| | Down-Regulation | 1 | 2015 | 657 | 0.030 |
Why?
| | Collagen | 1 | 2015 | 445 | 0.030 |
Why?
| | Blotting, Western | 1 | 2015 | 1225 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2015 | 621 | 0.030 |
Why?
| | Up-Regulation | 1 | 2015 | 843 | 0.020 |
Why?
| | Molecular Targeted Therapy | 1 | 2015 | 413 | 0.020 |
Why?
| | Indoles | 1 | 2015 | 410 | 0.020 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2015 | 434 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1354 | 0.020 |
Why?
| | Cell Survival | 1 | 2015 | 1117 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1274 | 0.020 |
Why?
| | Biopsy | 1 | 2015 | 1126 | 0.020 |
Why?
| | Sulfonamides | 1 | 2015 | 512 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2015 | 1731 | 0.020 |
Why?
| | Skin | 1 | 2015 | 745 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4018 | 0.020 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2015 | 804 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1768 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 10764 | 0.010 |
Why?
| | Child | 1 | 2023 | 21968 | 0.010 |
Why?
|
|
Rosenbaum's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|